Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

Pubblicazioni

Seladelpar: New hope for patients with primary biliary cholangitis

Autori: Yulia A Nevzorova, Francisco Javier Cubero
Pubblicato in: Med/ Cell Press, Numero 5 (5), 2024, ISSN 2666-6359
Editore: Science Direct
DOI: 10.1016/j.medj.2024.03.019

Mitochondrial cholesterol: Metabolism and impact on redox biology and disease

Autori: Leire Goicoechea,a,b,c Laura Conde de la Rosa,a,b,c Sandra Torres,a,b,c Carmen García-Ruiz,a,b,c,d,∗∗ and José C. Fernández-Checaa,b,c,d,∗
Pubblicato in: Redox Biology, 2023, ISSN 2213-2317
Editore: Elsevier
DOI: 10.1016/j.redox.2023.102643

Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis

Autori: Cristina Alarcón-Vila 1, Naroa Insausti-Urkia 1, Sandra Torres 1, Paula Segalés-Rovira 1, Laura Conde de la Rosa 1, Susana Nuñez 1, Raquel Fucho 1, Jose C Fernández-Checa 2, Carmen García-Ruiz 3
Pubblicato in: Redox Biology, 2023, ISSN 2213-2317
Editore: Elsevier BV
DOI: 10.1016/j.redox.2022.102596

aProceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

Autori: Alvarado Tapias E, Maya Miles D, Albillos A, Aller R, Ampuero J, Andrade R, Arechederra M, ASpicueta P, Banales, JM, Blas García A, Capparros E, Cardoso Delgado T, Carrillo Vico A, Claria J, Cubero FJ. Díaz Ruíz A, Fernández-Barrena MG, ..., Gahete DM
Pubblicato in: Gastroenterol Hepatol, 2024, ISSN 2444-3824
Editore: Elsevier
DOI: 10.1016/j.gastrohep.2024.502207

Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

Autori: Raquel Benedé, Francisco Javier Cubero, Yulia A. Nevzorova
Pubblicato in: Gut microbes, Numero 1, 2331460, 2024, ISSN 1949-0984
Editore: Taylor & Francis
DOI: 10.1080/19490976.2024.2331460

Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification

Autori: H. Niu, P. Solis-Muñoz, M. García-Cortés, J. Sanabria-Cabrera, M. Robles-Diaz, R. Romero-Flores, E. Bonilla-Toyos, A. Ortega-Alonso, J. M. Pinazo-Bandera, M. R. Cabello, F. Bessone, N. Hernandez, M. I. Lucena, R. J Andrade, I. Medina-Caliz, I. Álvarez-Álv
Pubblicato in: Pharmacological Research, Numero 199, 2024, ISSN 1043-6618
Editore: Academic Press
DOI: 10.1016/j.phrs.2023.107030

Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism

Autori: Francisco Javier Cubero; Pablo Sarobe; Gisa Tiegs
Pubblicato in: Gut, Numero 73, 2023, ISSN 0017-5749
Editore: BMJ Journals
DOI: 10.1136/gutjnl-2023-331048

JNKs protect from cholestatic liver disease progression by modulating Apelin signalling

Autori: Mohamed, Mohamed Ramadan; Haybaeck, Johannes; Wu, Hanghang; Su, Huan; Bartneck, Matthias; Lin, Cheng; Boekschoten, Mark V.; Boor, Peter; Goeppert, Benjamin; Rupp, Christian; Strnad, Pavel; Davis, Roger J.; Cubero, Francisco Javier; Trautwein, Christian
Pubblicato in: Crossref, 2023, ISSN 2589-5559
Editore: Elsevier
DOI: 10.1016/j.jhepr.2023.100854

Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury

Autori: Patricia Marañón 1, Esther Rey 2, Stephania C Isaza 2, Hanghang Wu 3, Patricia Rada 4, Carmen Choya-Foces 2, Antonio Martínez-Ruiz 5, María Ángeles Martín 6, Sonia Ramos 6, Carmelo García-Monzón 2, Francisco Javier Cubero 7, Ángela M Valverde 4, Águeda Go
Pubblicato in: Redox Biology, 2024, ISSN 2213-2317
Editore: Elsevier
DOI: 10.1016/j.redox.2024.103088

È in corso la ricerca di dati su OpenAIRE...

Pubblicazioni

Condividi questa pagina

Scarica